1/4 A Perspective on proximity-inducing #molecularglues and bifunctional compounds in relation to hot-spot-associated missense mutations enshrined by natural selection and posttranslational modifications (PTMs). https://t.co/7eFEtJfdnw
1/2 Why AI is unlikely to become conscious – my 2026 @TEDTalks is now online. What do you think about the prospects for 'conscious AI'? https://t.co/OoXFavR3eG
We found that participants in China attribute more consciousness to LLMs than participants in the UK. Interestingly, UK participants attribute more consciousness to octopuses.
If you’re interested in cultural differences or AI anthropomorphism, come say hi👋
A thoughtful and easy read from Angie You (@Angiejyou) on basic research as a driver of next-generation therapeutics, noting here clinical data from Revolution Medicines https://t.co/g8OgKYNt2r
Otsuka Unveils New Repinatrabit Open-Label Extension Data in Phenylketonuria (PKU) Signaling Efficacy in Adolescents at the 2026 American College of Medical Genetics and Genomics (ACMG) Meeting https://t.co/Dc5WsIr6NG
What a thrill to see this out! Our prospective, scalable, and target-centric solution for molecular glue discovery.
More thoughts and details here: https://t.co/k1Ylnzd3Cj
Paper here: https://t.co/XtTiavWZcr
Thanks to friends, colleagues, current and former group members, and the Welch Foundation for this video linking molecular glues, expanded genetic codes, and chemical biology https://t.co/kkobxKkEx8
Where Bold Science Meets Lasting Impact: Celebrating Discoveries That Inspire Arena BioWorks’ Commitment to Creativity and Innovation https://t.co/1OhL2PDmsb
I’m excited to team again with my long-time friend and colleague @HarveyJBerger at @arenabioworks. We can already feel the magic of the Ariad days as we translate Arena discoveries to high-impact medicines
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Biotech veteran @harveyjberger was named Chairman & CEO of @arenabioworks today - he describes how 'foraging to focusing' will be the name of the game.
Full video: https://t.co/LzuUOxB1L1
Excited to see this dynamic duo tackling high-impact biomedicine – among others, AI for reasoning on human evidence and AI for informed therapeutics https://t.co/AyTLAItzJZ
Under this ownership group, the Celtics won two championships and built a culture of camaraderie and resilience. Steve's deep loyalty to Boston makes him a champion both on and off the court, leaving a legacy that will forever inspire Celtics fans and Bostonians alike.
From @m2jr in Pattern Breakers (quote from William Gibson): "The future is already here; it's just not evenly distributed."
What's true of technology is true of medicine – we need insights into the inflection points to unlock transformative biotechs
#SXSW2025
It’s go time for @SXSW! 🚀...today with Jim Breyer
I’m excited to share the stage this afternoon with my longtime friend and one of the best in the business, @jimihendrixlive, to explore the forces that drive startups to outlier success.
Join us on the main stage (Salon H) at 2:30 PM for a session you won’t want to miss.
@PennChemistry@PennSAS@Penn Amos's brilliance illuminated every endeavor, but his kindness and generosity define his legacy. Heaven has gained a remarkable soul.
Congrats to the winners of the Stuart L. Schreiber Prize in Scientific Excellence presented at the @broadinstitute 's annual retreat! @JiaqiZhangVic (top) won for outstanding work on causal inference AI and @Smriti__Pandey (bottom) for pushing the frontiers of genome editing.
https://t.co/5EehCyFkG9
Compounds that recruit FKBP12 to novel targets with high cooperativity are the prototypical molecular glue and, represented by sirolimus and tacrolimus, have had major clinical impact. 1/3